BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32079950)

  • 21. Medical education and communication companies: an updated in-depth profile.
    Golden GA; Parochka JN; Overstreet KM
    J Contin Educ Health Prof; 2002; 22(1):55-62. PubMed ID: 12004641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interrater reliability to assure valid content in peer review of CME-accredited presentations.
    Quigg M; Lado FA
    J Contin Educ Health Prof; 2009; 29(4):242-5. PubMed ID: 19998446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rebuttal: Is CME a drug-promotion tool?: YES.
    Steinman MA; Baron RB
    Can Fam Physician; 2007 Nov; 53(11):1877, 1878-9. PubMed ID: 18000249
    [No Abstract]   [Full Text] [Related]  

  • 24. Examining the value of commercially supported CME.
    Miller LA
    J Contin Educ Health Prof; 2009; 29(1):68-70. PubMed ID: 19288557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rebuttal: Is CME a drug-promotion tool?: NO.
    Marlow B
    Can Fam Physician; 2007 Nov; 53(11):1877, 1878-9. PubMed ID: 18000248
    [No Abstract]   [Full Text] [Related]  

  • 26. Current guidelines regarding industry-sponsored continuing medical education.
    DelSignore JL
    Clin Orthop Relat Res; 2003 Jul; (412):21-7. PubMed ID: 12838047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defending professional independence: ACCME's proposed new guidelines for commercial support of CME.
    Relman AS;
    JAMA; 2003 May; 289(18):2418-20. PubMed ID: 12746367
    [No Abstract]   [Full Text] [Related]  

  • 28. "Academic" CME and the social contract.
    Davis D; Parboosingh J
    Acad Med; 1993 May; 68(5):329-32. PubMed ID: 8484835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinician attitudes about commercial support of continuing medical education: results of a detailed survey.
    Tabas JA; Boscardin C; Jacobsen DM; Steinman MA; Volberding PA; Baron RB
    Arch Intern Med; 2011 May; 171(9):840-6. PubMed ID: 21555662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating conflicts of interest in research presented in CME venues.
    Davis NL; Galliher JM; Spano MS; Main DS; Brannigan M; Pace WD
    J Contin Educ Health Prof; 2008; 28(4):220-7. PubMed ID: 19058257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical industry-sponsored meetings: good value or just a free meal?
    Carney SL; Nair KR; Sales MA; Walsh J
    Intern Med J; 2001 Nov; 31(8):488-91. PubMed ID: 11720063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug advertising, continuing medical education, and physician prescribing: a historical review and reform proposal.
    Rodwin MA
    J Law Med Ethics; 2010; 38(4):807-15. PubMed ID: 21105944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuing medical education and pharmaceutical industry involvement: An evaluation of policies adopted by Canadian professional medical associations.
    Shnier A; Lexchin J
    Int J Risk Saf Med; 2017; 29(1-2):1-16. PubMed ID: 28885217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commercial support and the quandary of continuing medical education.
    Schaffer MH
    J Contin Educ Health Prof; 2000; 20(2):120-6. PubMed ID: 11232220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ethics of industry support for professional education in medicine.
    Mamdani B
    Indian J Med Ethics; 2008; 5(4):177-80. PubMed ID: 18988379
    [No Abstract]   [Full Text] [Related]  

  • 36. Using Baldrige criteria to meet or exceed Accreditation Council for Continuing Medical Education Standards.
    Leist JC; Gilman SC; Cullen RJ; Sklar J
    J Contin Educ Health Prof; 2004; 24(1):57-63. PubMed ID: 15069913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in drug prescribing patterns related to commercial company funding of continuing medical education.
    Bowman MA; Pearle DL
    J Contin Educ Health Prof; 1988; 8(1):13-20. PubMed ID: 10294441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accreditation in India: Pathways and Mechanisms.
    Das S; Shah M; Mane A; Goyal V; Singh V; Lele J
    J Eur CME; 2018; 7(1):1454251. PubMed ID: 29755849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New standards for commercial support of CME: where are we headed?
    Bunnell KP
    J Cancer Educ; 1992; 7(3):203-7. PubMed ID: 1419584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.